top of page
Budapest_N.jpeg
Picture1.png

The 20th Annual Oligonucleotide Therapeutics Society Meeting was a resounding success!

On demand registration. Get access to the virtual presentations.

Virtual Registration Fee

Member Registration Fees

  • Student $435

  • Academia/Non-Profit $660

  • Industry $1403

Non-Member Registration Fees

  • Student $480

  • Academia/Non-Profit $780

  • Industry $1573

Meeting Keynote:

Annemieke Aartsma-Rus

From rare to extremely rare: Applying lessons learned from Duchenne muscular dystrophy antisense oligonucleotide mediated exon skipping to developing individualized treatment.

John Maraganore, PhD

Lifetime Achievement Award 2024

John Maraganore, PhD

Founding CEO & Director
Alnylam Pharmaceuticals 2002-2021

RNA.jpeg

Join leading experts in the field at the OTS Annual Meeting which will feature the latest developments from the various oligonucleotide-based disciplines.

​The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society's mission and goals, to foster academic and industry-based research for the development of oligonucleotide therapeutics. The meeting serves as a continuum for dialogue and discussion among industry, academia and health authorities to educate and share progress on the basic research and therapeutic development of oligonucleotides, including antisense, siRNA, immunostimulatory and aptamer applications, RNA/DNA editing and mRNA therapeutics as well as basic RNA research. Leaders in the field from across the globe alongside students (the Next Gen) will present in both general session and poster sessions.

The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics. The OTS offers scholarships, awards and travel grants annually. 

For details visit: 

Registration and abstract submissions will open by early May and will be announced via email and social media.

 Centre Mont-Royal 

Venue:

Centre Mont-Royal

OTS has multiple hotel options with a group rate offering for the 2024 meeting. 

Hotel Accommodations:

bottom of page